Delivery Order SPE2DR25D2014-SPE2DR26FZ97U
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Linezolid 600 mg tablets (quantity 20s) valued at $1,515.56 under a firm fixed-price contract. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a non-competitive delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,660.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20 units. The contract, with an ultimate completion date of September 10, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Linezolid 100 mg/5 ml suspension in 150 ml bottles. The award has a potential value of $1,269.66 and a completion date of February 6, 2024. This delivery order is likely issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LINEZOLID 600 MG TABLET 20S. The contract, valued at $12,003.54, was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order with a completion date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This delivery order, valued at $2,568.54, awards AmerisourceBergen Drug Corp the supply of Linezolid 290 MCG capsules (30-count units) under a firm fixed-price arrangement. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of November 26, 2025, just one day after the award date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency Troop Support Medical awarded a $844 delivery order to Amerisourcebergen Drug Corp for 600 mg tablets of linezolid. As the prime contractor, Amerisourcebergen will deliver 20 tablets of the antibiotic to a facility in Conshohocken, Pennsylvania by July 10, 2023 to fulfill requirements under the Prime Vendor Program contract vehicle. No subcontractors or set aside designations were indicated. The order supports DLA Troop Support Medical's mission to procure and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,496.63 on July 28, 2025, with a completion date of July 29, 2025. This non-set-aside contract procures VEOZAH 45 mg tablets in a 30-count package under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,705.93 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order (4568785087) is for pharmaceutical products specified as "DT 1C 2.25X4 700/RL 6RL/BX DHAPCL," to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement, consistent with...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ97UDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Linezolid 600 mg tablets in quantities of 20 units, with a contract value of $1,199.23. This firm fixed-price delivery order was awarded on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/14/25 |